Chairman Mai-Szu, WU  


  • Attending Physician, Nephrology Department, Taipei Chang Gung Memorial Hospital Postdoctoral

  • Research Fellow, French National Institute of Health and Medical Research (INSERM)

  • Director, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital

  • Associate Dean, School of Medicine, Taipei Medical University

  • Vice Superintendent for Education, Taipei Medical University Hospital

  • Vice Dean, School of Medicine, Taipei Medical University

  • Director, Management and Development Center, Taipei Medical University Hospital

  • Superintendent, Taipei Medical University Shuang Ho Hospital Hospital

  • Superintendent, Taipei Medical University New Taipei City Hospital

Current Position

  • Vice President, Taipei Medical University

  • President, Taiwan Society of Transplantation

  • Chairman of the Board, Kidney Disease Prevention and Treatment Foundation

Message from the Chairman

Kidney disease has always been a crucial issue in Taiwan and a global concern. The prevention and treatment of kidney disease have immense impacts on individuals, families, and nations. The prevalence and incidence of end-stage kidney disease in Taiwan have remained high, frequently capturing the attention of various news media outlets. The high prevalence and incidence of kidney disease in Taiwan are influenced by various factors. Firstly, the increasing number of diabetes patients contributes to chronic kidney disease, with diabetes being the most common risk factor. Poor blood sugar control often leads to kidney complications. Secondly, as Taiwan enters an aging society, improved overall health has allowed many chronic conditions to progress into end-stage kidney disease over time, presenting an important challenge for our future. Lastly, Taiwan's excellent healthcare environment ensures timely medical care for all citizens, regardless of their economic status, thus preventing scenarios where individuals cannot access dialysis due to financial limitations. We have been committed to promoting the prevention and treatment of chronic kidney disease. Much of our effort involves areas that the medical system and government education cannot cover comprehensively. As a private entity, the Kidney Disease Prevention and Treatment Foundation can independently contribute and make a difference where needed. The road to preventing and treating chronic kidney disease is still long, and we are just a small part of it. Over the past decade, the foundation has extended its reach from communities and schools to remote areas. We aim to fulfill the responsibilities and obligations of the foundation, conveying accurate health education concepts to those who need it most. In the next decade, we will strive to promote healthy living and incorporate correct kidney disease prevention and treatment concepts, including dietary and lifestyle habits, into everyone's lives. Our goal is to reduce the number of people suffering from kidney disease in Taiwan and work together to create a better new Taiwan and a better world.

CEO Yu-feng Lin


  • Associate Vice President for Academics, Taipei Medical University and Shuang Ho Hospital
  • Director, Institute of Clinical Medicine, Taipei Medical University Deputy Chair, Department of Medicine, School of Medicine, Taipei Medical University
  • Executive Director, Taiwan Society of Nephrology

Current Position

  • CEO, Kidney Disease Prevention and Treatment Foundation
  • Director, Chuan Hsin Yuan Clinic

Message from the CEO

Chronic kidney disease in its early and middle stages often lacks obvious symptoms, leading to low awareness (3.5%) but a high prevalence (12%). It has become a national health concern, following liver disease. With over 90,000 kidney dialysis patients and annual medical expenses exceeding 50 billion NT dollars, the prevention and treatment of kidney disease is an urgent nationwide effort.

Chronic kidney disease is preventable and treatable. As early as 2003, the Taiwan Society of Nephrology collaborated with the Department of Health to establish kidney disease health promotion institutions in medical institutions nationwide, totaling more than a hundred. The National Health Insurance Administration and the nephrology community have successively introduced programs like "Preventive Plan for Early Stages of End-Stage Kidney Disease and Patient Health Education" and "Early Chronic Kidney Disease Treatment Improvement Program." These efforts have led to the creation of a chronic kidney disease and dialysis database, yielding remarkable results. The incidence of chronic kidney disease has been gradually slowing, and our comprehensive care and monitoring of cases have earned praise and emulation from around the world.

Since 2008, the Bureau of National Health Insurance, the National Development Council, and the Taiwan Society of Nephrology have initiated a national chronic kidney disease prevention and treatment program, investigating risk and deterioration factors, establishing a kidney disease database, offering governmental prevention and treatment policies, and creating annual reports and national epidemiological data. The prevention and treatment of chronic kidney disease is a nationwide endeavor. In addition to the efforts of the government, medical institutions, and associations, the establishment of the Kidney Disease Prevention and Treatment Foundation aims to promote the enhancement of knowledge regarding kidney and related diseases across the population, ultimately preventing the occurrence and progression of kidney disease.

Organization Chart

The foundation is a nonprofit corporation dedicated to promoting the prevention, care, and educational research of kidney diseases. The foundation consists of one chairman, fifteen directors, and five supervisors, all serving on a voluntary basis. Their term is three years and can be renewed. The chairman is elected by the current directors and represents the foundation externally while overseeing all its affairs.





  • 董事長

  • 董 事

  • 監察人